SCHEMBL4062483

SCHEMBL4062483

CCCCCCCCCCCC/C=C/I

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 4/20 0.54
TRPV1 Q8NER1 1/20 0.54
TERT O14746 3/20 0.52
PTPN1 P18031 3/20 0.52
PPARG P37231 3/20 0.52
PPARD Q03181 3/20 0.52
PPARA Q07869 3/20 0.52
CYP1A2 P05177 2/20 0.52
MAPT P10636 2/20 0.52
CYP2C19 P33261 2/20 0.52
BLM P54132 2/20 0.52
HSD17B10 Q99714 2/20 0.52
FABP4 P15090 2/20 0.52
KMT2A Q03164 2/20 0.52
TOP1 P11387 2/20 0.52
GMNN O75496 1/20 0.52
USP2 O75604 1/20 0.52
LMNA P02545 1/20 0.52
POLB P06746 1/20 0.52
CYP2C9 P11712 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9232315 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1615635 1.00
SCHEMBL1043632 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1043631 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14353253 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14830402 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL10868764 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL14830401 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL771891 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG
SCHEMBL1904390 1.00 FAAH (0.54) FAAHTRPV1TERTPTPN1PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118725325-A Method for improving freezing resistance of metal-organic framework and application of method in erythrocyte freezing protection 华南理工大学 2024-10-01 CN claimed
CN-118725325-A Method for improving freezing resistance of metal-organic framework and application of method in erythrocyte freezing protection 华南理工大学 2024-10-01 CN disclosed
EP-3104426-A1 ORGANIC TRANSISTOR, COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL FOR NON-LUMINESCENT ORGANIC SEMICONDUCTOR DEVICE, MATERIAL FOR ORGANIC TRANSISTOR, COATING SOLUTION FOR NON-LUMINESCENT ORGANIC SEMICONDUCTOR DEVICE, AND ORGANIC SEMICONDUCTOR FILM FOR NON-LUMINESCENT ORGANIC SEMICONDUCTOR DEVICE Fujifilm Corporation (JP) 2016-12-14 EP disclosed
US-7553988-B2 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMTED (JP) 2009-06-30 US disclosed
EP-1439157-B1 Method for producing Suzuki coupling compound catalysed by a nickel compound SUMITOMO CHEMICAL CO (JP) 2007-07-11 EP disclosed
US-7238832-B2 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-07-03 US disclosed
US-7217677-B2 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2007-05-15 US disclosed
US-20060281925-A1 METHOD FOR PRODUCING COUPLING COMPOUND SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2006-12-14 US disclosed
EP-1449580-B1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound SUMITOMO CHEMICAL CO (JP) 2005-12-28 EP disclosed
US-20040167364-A1 Production method of a coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-26 US disclosed
EP-1449580-A1 Production method of a cross-coupling compound from an alkyl halide and an organoboron compound Sumitomo Chemical Co.,Ltd. (JP) 2004-08-25 EP disclosed
US-20040161404-A1 Method for producing coupling compound SUMITOMO CHEMICAL COMPANY, LIMITED 2004-08-19 US disclosed
EP-1439157-A2 Method for producing Suzuki coupling compound catalysed by a nickel compound Sumitomo Chemical Co.,Ltd. (JP) 2004-07-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040167364-A1 Production method of a coupling compound PYM1, BRIX1, CXCR1 FAAH 3322/4885TRPV1 4610/4885TERT 1153/4885
US-20060281925-A1 METHOD FOR PRODUCING COUPLING COMPOUND RPL22, CYP4A22, PYM1 FAAH 3264/4885TRPV1 4130/4885TERT 1958/4885
US-20040161404-A1 Method for producing coupling compound PYM1, MALT1, BET1 FAAH 2002/4885TRPV1 4241/4885TERT 1058/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.